Atlas Trials

Malignant Melanoma Stage III

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Malignant Melanoma Stage III

RecordFirmDate
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma (NCT06794775)Hildur Helgadottir2025-07-10
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma (NCT04949113)The Netherlands Cancer Institute2021-07-08
The IRMI-FMT Trial (NCT04577729)Medical University of Graz2021-05-21
Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (NCT04133948)The Netherlands Cancer Institute2020-01-07
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ) (NCT03493230)Centre Hospitalier Universitaire de Nice2018-04-24
Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (NCT02977052)The Netherlands Cancer Institute2016-11-24
mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma (NCT01676779)Universitair Ziekenhuis Brussel2012-10-01
Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma (NCT01302496)Bart Neyns2011-02-01
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma (NCT01189383)Baylor Research Institute2011-01-01

Track Malignant Melanoma Stage III automatically

Every clearance here is in the API, with alerts when new ones post.